Thanks for the interesting analysis! I have been building up a substantial position in Novo Nordisk. Of course, it has some challenges, but the valuation is very attractive in my perspective. It is ridiculous the company is priced now at pre-Ozempic levels.
Thanks for the interesting analysis! I have been building up a substantial position in Novo Nordisk. Of course, it has some challenges, but the valuation is very attractive in my perspective. It is ridiculous the company is priced now at pre-Ozempic levels.
What do you think?